Orchestra Biomed Holdings (OBIO)Director bought ~$20K

~$20K

Approx. value · 5,000 sh @ $4.07

613K

Holds after · shares reported

Traded

Nov 14, 2025

Filed

Nov 17, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Sep 19, 2025Insider · Their first buy on recordDirector purchased ~$2.5K of OBIO shares in the open market
2. Oct 24, 2025Company filing · Form 8-K · Material agreement, Agreement endedSigned an important agreement, and ended an important agreement (and 3 more items)
3. Nov 14, 2025 · this disclosureInsiderDirector purchased ~$20K of OBIO shares in the open market

What came next

1. Feb 12, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 12, 2026, the Board of Directors (the “ Board ”) of Orchestra BioMed Holdings, Inc. (the “ Company ”), upon the recommendation of the Compensation Committee of the Board (the “ Compensation Committee ”), approved the 2026 cash bonus plan for all executive officers (the “ Plan ”), which: · establishes annual goals with mid-year key deliverables approved by the Committee or the Board; · provides for a…”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Orchestra Biomed Holdings

For Orchestra Biomed Holdings, OQRO holds 5 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its OBIO page.

Other recent filings by David P Hochman, See Remarks

• SEC Form 4 at Orchestra Biomed Holdings (OBIO)Sep 8, 2026
• SEC Form 4 at Orchestra Biomed Holdings (OBIO)Jun 2, 2026
• SEC Form 4 at Orchestra Biomed Holdings (OBIO)May 19, 2026
• SEC Form 4 at Orchestra Biomed Holdings (OBIO)Mar 16, 2026
• SEC Form 4 at Orchestra Biomed Holdings (OBIO)Aug 25, 2025

The full history of David P Hochman, See Remarks is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Orchestra Biomed Holdings

• SEC Form 4Oct 2, 2026
• SEC Form 4Sep 8, 2026
• SEC Form 4Sep 2, 2026
• SEC Form 4Aug 28, 2026
• SEC Form 13F-HRAug 14, 2026
• SEC Form 4Aug 4, 2026

Everything OQRO holds on this company is on its OBIO page.